GHS-R1a Interaction
Ipamorelin is studied primarily as an agonist of GHS-R1a, also called the ghrelin receptor.
Ipamorelin
Selective GHS-R1a Agonist | Research Grade | Lyophilized Pentapeptide
Third-Party Tested
Cold Chain Shipping
COA Included
Secure CheckoutDiscreet PackagingWorldwide Shipping
Mechanism of Action
Ipamorelin is a synthetic pentapeptide studied as a selective growth-hormone secretagogue receptor agonist. It acts primarily through GHS-R1a, the ghrelin receptor, and is not a GHRH analogue or directly administered growth hormone. Research examines pulsatile pituitary GH release and downstream somatotropic signalling; findings depend on the model, experimental conditions and quality of the available evidence.
Pulsatile GH Release
Experimental models examine receptor signalling associated with pulsatile pituitary growth-hormone release.
Somatotropic Axis
Research evaluates downstream GH and possible indirect IGF-1 signalling without equating either with a clinical outcome.
Reported Selectivity
Pharmacology studies report greater receptor-response selectivity than some earlier GH secretagogues; significance remains model-dependent.
Ipamorelin Research Overview
Ghrelin-Receptor Signalling
In vitro work characterizes binding and signalling at GHS-R1a; these mechanistic observations do not establish an approved medical indication.
GH–IGF-1 Axis Research
Preclinical and limited human research may measure GH release and downstream IGF-1-related signals under controlled conditions.
Metabolic Models
Energy metabolism and body-composition markers are research endpoints, not evidence of guaranteed fat loss or muscle gain.
Tissue Research
Preclinical models explore tissue renewal and recovery hypotheses; direct repair effects in humans should not be inferred.
Distinct from CJC-1295
Ipamorelin targets the ghrelin-receptor pathway. CJC-1295 is associated with GHRH signalling, so the compounds do not act at the same receptor.
What’s Included
Reconstitution Guide
How to prepare your peptide safely.
PDF GuideResearch Dosing Guide
Recommended research dosage protocols.
PDF GuideClinical Research Digest
Latest clinical research and key findings.
PDF GuideMechanism of Action
Simple visual explanation of how it works.
PDF GuideInstant Digital AccessAvailable immediately after your order is confirmed.
Ipamorelin FAQ
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide studied as a growth-hormone secretagogue and selective agonist of GHS-R1a. ELIX LABS supplies it exclusively as an experimental research compound.
What is the GHS-R1a receptor?
GHS-R1a is the growth-hormone secretagogue receptor, commonly called the ghrelin receptor. It is a signalling receptor involved in neuroendocrine and metabolic research.
How does Ipamorelin interact with the ghrelin receptor?
Mechanistic studies examine Ipamorelin binding to and activating GHS-R1a. The resulting intracellular signalling can be associated with pituitary GH release in experimental systems.
How is Ipamorelin studied in growth-hormone research?
Researchers may evaluate receptor activity, the timing and magnitude of pulsatile GH release, and downstream somatotropic markers. Results vary by model, design and evidence quality.
Is Ipamorelin the same as growth hormone?
No. Ipamorelin is a receptor agonist studied for stimulating endogenous GH release; it is not growth hormone administered directly.
Is Ipamorelin a GHRH analogue?
No. Ipamorelin is studied through GHS-R1a, whereas GHRH analogues act through the GHRH receptor.
How does Ipamorelin differ from CJC-1295?
Ipamorelin is associated with the ghrelin-receptor pathway. CJC-1295 is associated with the GHRH pathway, so they do not act on the same receptor.
What is the relationship between Ipamorelin, GH and IGF-1?
GHS-R1a activation may stimulate experimental GH release, which can influence downstream IGF-1 signalling. That sequence is indirect and depends on the biological model and study conditions.
Does growth-hormone release automatically indicate muscle growth?
No. A measured increase in GH release does not by itself demonstrate increased muscle mass. Body-composition outcomes require separate, appropriately controlled evidence.
What does the reported selectivity of Ipamorelin mean?
It refers to pharmacology findings suggesting a more focused GH-secretagogue response than some earlier compounds. It does not establish safety, efficacy or an approved therapeutic use.
How should lyophilized Ipamorelin be stored for research?
Keep the sealed lyophilized material refrigerated at 2–8°C, protected from light and moisture, and follow the batch documentation and laboratory handling requirements.
Is the ELIX LABS product intended for human use?
No. It is supplied exclusively for laboratory research and is not intended for human or veterinary use, diagnosis, treatment or any approved medical indication.
What documentation is included with the product?
The order includes the four listed research resources and batch-related analytical documentation where applicable. Consult the supplied documents for laboratory handling and traceability information.